Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
A Chromosome 21 Critical Region Does Not Cause Specific Down Syndrome Phenotypes
L. E. Olson,1*J. T. Richtsmeier,2J. Leszl,2R. H. Reeves1
The "Down syndrome critical region" (DSCR) is a chromosome 21segment purported to contain genes responsible for many featuresof Down syndrome (DS), including craniofacial dysmorphology.We used chromosome engineering to create mice that were trisomicor monosomic for only the mouse chromosome segment orthologousto the DSCR and assessed dysmorphologies of the craniofacialskeleton that show direct parallels with DS in mice with a largersegmental trisomy. The DSCR genes were not sufficient and werelargely not necessary to produce the facial phenotype. Theseresults refute specific predictions of the prevailing hypothesisof gene action in DS.
1 Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. 2 Department of Anthropology and Program in Genetics, Pennsylvania State University, University Park, PA 16802, USA.
* Present address: Department of Biology, University of Redlands,Redlands, CA 92373, USA.
To whom correspondence should be addressed. E-mail: rreeves{at}jhmi.edu
The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies.
J. O. Korbel, T. Tirosh-Wagner, A. E. Urban, X.-N. Chen, M. Kasowski, L. Dai, F. Grubert, C. Erdman, M. C. Gao, K. Lange, et al. (2009)
PNAS
106, 12031-12036
|Abstract »|Full Text »|PDF »
Aneuploidy: From a Physiological Mechanism of Variance to Down Syndrome.
The "Down Syndrome Critical Region" Is Sufficient in the Mouse Model to Confer Behavioral, Neurophysiological, and Synaptic Phenotypes Characteristic of Down Syndrome.
N. P. Belichenko, P. V. Belichenko, A. M. Kleschevnikov, A. Salehi, R. H. Reeves, and W. C. Mobley (2009)
J. Neurosci.
29, 5938-5948
|Abstract »|Full Text »|PDF »
Down syndrome--recent progress and future prospects.
F. K. Wiseman, K. A. Alford, V. L.J. Tybulewicz, and E. M.C. Fisher (2009)
Hum. Mol. Genet.
18, R75-R83
|Abstract »|Full Text »|PDF »
Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome.
Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome.
F. Liu, Z. Liang, J. Wegiel, Y.-W. Hwang, K. Iqbal, I. Grundke-Iqbal, N. Ramakrishna, and C.-X. Gong (2008)
FASEB J
22, 3224-3233
|Abstract »|Full Text »|PDF »
Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.
G. Kirsammer, S. Jilani, H. Liu, E. Davis, S. Gurbuxani, M. M. Le Beau, and J. D. Crispino (2008)
Blood
111, 767-775
|Abstract »|Full Text »|PDF »
Modeling the monosomy for the telomeric part of human chromosome 21 reveals haploinsufficient genes modulating the inflammatory and airway responses.
V. Besson, V. Brault, A. Duchon, D. Togbe, J.-C. Bizot, V. F.J. Quesniaux, B. Ryffel, and Y. Herault (2007)
Hum. Mol. Genet.
16, 2040-2052
|Abstract »|Full Text »|PDF »
Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities.
Z. Li, T. Yu, M. Morishima, A. Pao, J. LaDuca, J. Conroy, N. Nowak, S.-I. Matsui, I. Shiraishi, and Y. E. Yu (2007)
Hum. Mol. Genet.
16, 1359-1366
|Abstract »|Full Text »|PDF »
Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
L. E. Olson, R. J. Roper, C. L. Sengstaken, E. A. Peterson, V. Aquino, Z. Galdzicki, R. Siarey, M. Pletnikov, T. H. Moran, and R. H. Reeves (2007)
Hum. Mol. Genet.
16, 774-782
|Abstract »|Full Text »|PDF »
Ts65Dn, a Mouse Model of Down Syndrome, Exhibits Increased GABAB-Induced Potassium Current.
T. K. Best, R. J. Siarey, and Z. Galdzicki (2007)
J Neurophysiol
97, 892-900
|Abstract »|Full Text »|PDF »
New techniques to understand chromosome dosage: mouse models of aneuploidy.
V. L.J. Tybulewicz and E. M.C. Fisher (2006)
Hum. Mol. Genet.
15, R103-R109
|Abstract »|Full Text »|PDF »
Scientific and clinical opportunities for modeling blood disorders with embryonic stem cells.
An Aneuploid Mouse Strain Carrying Human Chromosome 21 with Down Syndrome Phenotypes.
A. O'Doherty, S. Ruf, C. Mulligan, V. Hildreth, M. L. Errington, S. Cooke, A. Sesay, S. Modino, L. Vanes, D. Hernandez, et al. (2005)
Science
309, 2033-2037
|Abstract »|Full Text »|PDF »
Dissecting the genetic complexity of human 6p deletion syndromes by using a region-specific, phenotype-driven mouse screen.
D. Bogani, C. Willoughby, J. Davies, K. Kaur, G. Mirza, A. Paudyal, H. Haines, R. McKeone, M. Cadman, G. Pieles, et al. (2005)
PNAS
102, 12477-12482
|Abstract »|Full Text »|PDF »
Segmental trisomy of chromosome 17: A mouse model of human aneuploidy syndromes.
T. Vacik, M. Ort, S. Gregorova, P. Strnad, R. Blatny, N. Conte, A. Bradley, J. Bures, and J. Forejt (2005)
PNAS
102, 4500-4505
|Abstract »|Full Text »|PDF »